AUA Best Practice Statement for the Prevention of Deep Vein Thrombosis in Patients Undergoing Urologic Surgery

摘要

INTRODUCTION Deep vein thrombosis (DVT) with its potential fatal sequela of pulmonary thromboembolism (PTE) is a common complication of surgical procedures and thus an issue of importance for practicing urologists. In fact, PTE is one of the most common causes of nonsurgical death in patients undergoing urologic surgery.1 In addition to the mortality associated with PTE, long-term complications such as post-thrombotic syndromes can occur with significant morbidity2'3 and economic impact.4 Because of the enormity of the problem and its potential for preventable mortality and morbidity, DVT prophylaxis has been identified by a number of organizations as a marker of good quality of patient care. At the request of the Board of Directors (BOD) of the American Urological Association (AUA) and under the guidance of the Practice Guidelines Committee (PGC) of the AUA, a Panel was convened to develop a Best Practice Statement for the prevention of DVT in patients undergoing urologic surgery